Charalambos (Babis) Andreadis

MD

Hematologist
Cancer therapy researcher and food aficionado

About me

Dr. Charalambos (Babis) Andreadis specializes in bone marrow transplantation for adults and in treating Hodgkin's and non-Hodgkin's lymphoma, leukemia and multiple myeloma. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. His research, published widely in scientific journals, examines genetic and other factors that affect how patients respond to therapy, including degrees of drug toxicity. He also studies patient outcomes in these disorders.

Andreadis earned his medical degree at Columbia University's Vagelos College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha Honor Medical Society in 1998. He completed a residency at New York-Presbyterian Hospital and a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. He also earned a master's degree in clinical epidemiology at the University of Pennsylvania, focusing on pharmacogenetics, the study of how genes impact an individual's response to medications.

  • Education

    Columbia University College of Physicians and Surgeons, 1998

  • Residencies

    Columbia Presbyterian Medical Center, Internal Medicine, 2001

  • Fellowships

    University of Pennsylvania, Hematology-Oncology, 2004

  • Academic Title

    Professor

  • Languages

    Greek

    Spanish

I aspire to guiding patients through diagnosis, treatment and recovery with a scientifically rigorous and highly personalized approach.

Clinics I work with

Hematology, Blood & Marrow Transplant, and Cellular Therapies (HBC) Program

400 Parnassus Ave., Fourth Floor
San Francisco, CA 94143

My reviews

4.9

Overall Experience
211 Reviews
Explained things in a way that was easy to understand
207 Reviews
Did the doctor pay attention to your concerns
207 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
205 Reviews
Knew the important information about your medical history
208 Reviews
The provider showed respect for what you had to say
209 Reviews
The provider spent enough time with me
208 Reviews
Decorative Caduceus

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin...

All subjects enrolled in this phase I study who actually received study drug (anti-CD19 CAR-T infusion) will be included in the analysis. Proportion of participants with treatment-emergent adverse events of CAR-T in B-cell NHL, as...

Recruiting

Decorative Caduceus

Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy

Will calculate the uniformly minimum-variance unbiased estimator, p-value and 95% confidence interval (CI) for the response rates.

Recruiting

Share